Abciximab
Naproxen may increase the anticoagulant activities of Abciximab.
Abiraterone
The serum concentration of Naproxen can be increased when it is combined with Abiraterone.
Acebutolol
Naproxen may decrease the antihypertensive activities of Acebutolol.
Advertisement
Aceclofenac
The risk or severity of adverse effects can be increased when Naproxen is combined with Aceclofenac.
Acemetacin
The risk or severity of adverse effects can be increased when Naproxen is combined with Acemetacin.
Acenocoumarol
Naproxen may increase the anticoagulant activities of Acenocoumarol.
Advertisement
Acetyl salicylate
The risk or severity of adverse effects can be increased when Naproxen is combined with Acetylsalicylic acid.
Aclarubicin
Naproxen may decrease the excretion rate of Aclarubicin which could result in a higher serum level.
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Naproxen.
Advertisement
Alclometasone
The risk or severity of adverse effects can be increased when Naproxen is combined with Alclometasone.
Aldosterone
The risk or severity of adverse effects can be increased when Naproxen is combined with Aldosterone.
Alendronate
The risk or severity of adverse effects can be increased when Naproxen is combined with Alendronic acid.
Alendronic acid
The risk or severity of adverse effects can be increased when Naproxen is combined with Alendronic acid.
Aliskiren
Naproxen may decrease the antihypertensive activities of Aliskiren.
Alminoprofen
The risk or severity of adverse effects can be increased when Naproxen is combined with Alminoprofen.
Alprenolol
Naproxen may decrease the antihypertensive activities of Alprenolol.
Alprostadil
The therapeutic efficacy of Alprostadil can be decreased when used in combination with Naproxen.
Amcinonide
The risk or severity of adverse effects can be increased when Naproxen is combined with Amcinonide.
Amikacin
Naproxen may decrease the excretion rate of Amikacin which could result in a higher serum level.
Amiloride
Naproxen may decrease the antihypertensive activities of Amiloride.
Amiodarone
The metabolism of Naproxen can be decreased when combined with Amiodarone.
Ancrod
Naproxen may increase the anticoagulant activities of Ancrod.
Androstenedione
The risk or severity of adverse effects can be increased when Naproxen is combined with Androstenedione.
Anhydrous Tacrolimus
Naproxen may increase the nephrotoxic activities of Tacrolimus.
Antipyrine
The risk or severity of adverse effects can be increased when Naproxen is combined with Antipyrine.
Antithrombin III
Naproxen may increase the anticoagulant activities of Antithrombin III human.
Antithrombin III, Human
Naproxen may increase the anticoagulant activities of Antithrombin III human.
Apalutamide
The serum concentration of Naproxen can be decreased when it is combined with Apalutamide.
Apazone
The risk or severity of adverse effects can be increased when Naproxen is combined with Azapropazone.
Apixaban
The risk or severity of adverse effects can be increased when Naproxen is combined with Apixaban.
Apremilast
The risk or severity of adverse effects can be increased when Naproxen is combined with Apremilast.
Aprepitant
The metabolism of Naproxen can be increased when combined with Aprepitant.
Arbekacin
Naproxen may decrease the excretion rate of Arbekacin which could result in a higher serum level.
Ardeparin
Naproxen may increase the anticoagulant activities of Ardeparin.
Argatroban
Naproxen may increase the anticoagulant activities of Argatroban.
Argatroban Anhydrous
Naproxen may increase the anticoagulant activities of Argatroban.
Aspirin
The risk or severity of adverse effects can be increased when Naproxen is combined with Acetylsalicylic acid.
Atenolol
Naproxen may decrease the antihypertensive activities of Atenolol.
Azelastine
The risk or severity of adverse effects can be increased when Naproxen is combined with Azelastine.
azficel-T
The risk or severity of adverse effects can be increased when Naproxen is combined with Azficel-T.
Azilsartan
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Naproxen.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Naproxen.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Naproxen.
Azithromycin
The metabolism of Naproxen can be decreased when combined with Azithromycin.
Azosemide
The therapeutic efficacy of Azosemide can be decreased when used in combination with Naproxen.
Balsalazide
Naproxen may increase the nephrotoxic activities of Balsalazide.
Becaplermin
Naproxen may increase the anticoagulant activities of Becaplermin.
Beclomethasone Dipropionate
The risk or severity of adverse effects can be increased when Naproxen is combined with Beclomethasone dipropionate.
Benazepril
The risk or severity of adverse effects can be increased when Naproxen is combined with Benazepril.
Bendroflumethiazide
The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Naproxen.
Benzydamine
The risk or severity of adverse effects can be increased when Naproxen is combined with Benzydamine.
Betamethasone
The risk or severity of adverse effects can be increased when Naproxen is combined with Betamethasone.
Betaxolol
Naproxen may decrease the antihypertensive activities of Betaxolol.
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Naproxen.
Bimatoprost
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Naproxen.
Bisoprolol
Naproxen may decrease the antihypertensive activities of Bisoprolol.
Bivalirudin
Naproxen may increase the anticoagulant activities of Bivalirudin.
Bopindolol
Naproxen may decrease the antihypertensive activities of Bopindolol.
Bortezomib
The metabolism of Naproxen can be decreased when combined with Bortezomib.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Naproxen.
Budesonide
The risk or severity of adverse effects can be increased when Naproxen is combined with Budesonide.
Bufexamac
The risk or severity of adverse effects can be increased when Naproxen is combined with Bufexamac.
Bumetanide
The therapeutic efficacy of Bumetanide can be decreased when used in combination with Naproxen.
Bupranolol
Naproxen may decrease the antihypertensive activities of Bupranolol.
Caffeine
The metabolism of Naproxen can be decreased when combined with Caffeine.
Candesartan
The risk or severity of adverse effects can be increased when Candesartan is combined with Naproxen.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Naproxen.
Capecitabine
The metabolism of Naproxen can be decreased when combined with Capecitabine.
Captopril
The risk or severity of adverse effects can be increased when Naproxen is combined with Captopril.
Carbamazepine
The metabolism of Naproxen can be increased when combined with Carbamazepine.
Carboprost
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Naproxen.
Carboprost Tromethamine
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Naproxen.
Carprofen
The risk or severity of adverse effects can be increased when Naproxen is combined with Carprofen.
Carteolol
Naproxen may decrease the antihypertensive activities of Carteolol.
Carvedilol
Naproxen may decrease the antihypertensive activities of Carvedilol.
Celecoxib
The risk or severity of adverse effects can be increased when Naproxen is combined with Celecoxib.
Celiprolol
Naproxen may decrease the antihypertensive activities of Celiprolol.
Ceritinib
The serum concentration of Naproxen can be increased when it is combined with Ceritinib.
Certoparin
Naproxen may increase the anticoagulant activities of Certoparin.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Naproxen.
Chlorothiazide
The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Naproxen.
Chlorthalidone
The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Naproxen.
Cholecalciferol
The metabolism of Naproxen can be decreased when combined with Cholecalciferol.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Naproxen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Naproxen is combined with Choline magnesium trisalicylate.
Ciclesonide
The risk or severity of adverse effects can be increased when Naproxen is combined with Ciclesonide.
Cilazapril
The risk or severity of adverse effects can be increased when Naproxen is combined with Cilazapril.
Cinoxacin
Naproxen may increase the neuroexcitatory activities of Cinoxacin.
Citalopram
The metabolism of Naproxen can be decreased when combined with Citalopram.
Citric Acid
Naproxen may increase the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Naproxen may increase the anticoagulant activities of Citric Acid.
Clobetasol
The risk or severity of adverse effects can be increased when Naproxen is combined with Clobetasol.
Clobetasol Propionate
The risk or severity of adverse effects can be increased when Naproxen is combined with Clobetasol propionate.
Clobetasone
The risk or severity of adverse effects can be increased when Naproxen is combined with Clobetasone.
Clocortolone
The risk or severity of adverse effects can be increased when Naproxen is combined with Clocortolone.
Clodronic Acid
The risk or severity of adverse effects can be increased when Naproxen is combined with Clodronic Acid.
Clofezone
The metabolism of Naproxen can be decreased when combined with Rabeprazole.
Clonixin
The risk or severity of adverse effects can be increased when Naproxen is combined with Clonixin.
Clotrimazole
The metabolism of Naproxen can be decreased when combined with Clotrimazole.
Colesevelam
Colesevelam can cause a decrease in the absorption of Naproxen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Naproxen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cortisone Acetate
The risk or severity of adverse effects can be increased when Naproxen is combined with Cortisone acetate.
Crisaborole
The metabolism of Naproxen can be decreased when combined with Crisaborole.
Curcumin
The risk or severity of adverse effects can be increased when Naproxen is combined with Curcumin.
Cyclopenthiazide
The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Naproxen.
Cyclosporine
Naproxen may increase the nephrotoxic activities of Cyclosporine.
Cyproterone Acetate
The serum concentration of Naproxen can be decreased when it is combined with Cyproterone acetate.
Dabigatran Etexilate
Naproxen may increase the anticoagulant activities of Dabigatran etexilate.
Dabrafenib
The serum concentration of Naproxen can be decreased when it is combined with Dabrafenib.
Dalteparin
Naproxen may increase the anticoagulant activities of Dalteparin.
Danaparoid
Naproxen may increase the anticoagulant activities of Danaparoid.
Daunorubicin
Naproxen may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Deferasirox
The serum concentration of Naproxen can be increased when it is combined with Deferasirox.
Deflazacort
The risk or severity of adverse effects can be increased when Naproxen is combined with Deflazacort.
Delavirdine
The metabolism of Naproxen can be decreased when combined with Delavirdine.
Desirudin
Naproxen may increase the anticoagulant activities of Desirudin.
Desmopressin
The risk or severity of adverse effects can be increased when Naproxen is combined with Desmopressin.
Desonide
The risk or severity of adverse effects can be increased when Naproxen is combined with Desonide.
Desoximetasone
The risk or severity of adverse effects can be increased when Naproxen is combined with Desoximetasone.
Desoxycorticosterone acetate
The risk or severity of adverse effects can be increased when Naproxen is combined with Desoxycorticosterone acetate.
Desoxycorticosterone Pivalate
The risk or severity of adverse effects can be increased when Naproxen is combined with Desoxycorticosterone Pivalate.
Dexamethasone
The risk or severity of adverse effects can be increased when Naproxen is combined with Dexamethasone.
Dexketoprofen
The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Naproxen.
Dextran
Naproxen may increase the anticoagulant activities of Dextran.
Dextran 40
Naproxen may increase the anticoagulant activities of Dextran 40.
Dextran 70
Naproxen may increase the anticoagulant activities of Dextran 70.
Dextran 75
Naproxen may increase the anticoagulant activities of Dextran 75.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Naproxen.
Dicumarol
Naproxen may increase the anticoagulant activities of Dicoumarol.
Diflorasone
The risk or severity of adverse effects can be increased when Naproxen is combined with Diflorasone.
Diflucortolone
The risk or severity of adverse effects can be increased when Naproxen is combined with Difluocortolone.
Diflunisal
The risk or severity of adverse effects can be increased when Naproxen is combined with Diflunisal.
Difluprednate
The risk or severity of adverse effects can be increased when Naproxen is combined with Difluprednate.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Naproxen.
Dihydrostreptomycin
Naproxen may decrease the excretion rate of Dihydrostreptomycin which could result in a higher serum level.
Dinoprost
The therapeutic efficacy of Dinoprost can be decreased when used in combination with Naproxen.
Dinoprost Tromethamine
The therapeutic efficacy of Dinoprost Tromethamine can be decreased when used in combination with Naproxen.
Dinoprostone
The therapeutic efficacy of Dinoprostone can be decreased when used in combination with Naproxen.
Dipyrone
The risk or severity of adverse effects can be increased when Naproxen is combined with Metamizole.
Dothiepin
The metabolism of Naproxen can be decreased when combined with Dosulepin.
Doxorubicin
Naproxen may decrease the excretion rate of Doxorubicin which could result in a higher serum level.
Doxorubicin Hydrochloride
Naproxen may decrease the excretion rate of Doxorubicin which could result in a higher serum level.
Drospirenone
Naproxen may increase the hyperkalemic activities of Drospirenone.
Droxicam
The risk or severity of adverse effects can be increased when Naproxen is combined with Droxicam.
Edetic Acid
Naproxen may increase the anticoagulant activities of Edetic Acid.
Edoxaban
Naproxen may increase the anticoagulant activities of Edoxaban.
Efavirenz
The metabolism of Naproxen can be decreased when combined with Efavirenz.
Enalapril
The risk or severity of adverse effects can be increased when Naproxen is combined with Enalapril.
Enalaprilat
The risk or severity of adverse effects can be increased when Naproxen is combined with Enalaprilat.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Naproxen is combined with Enalaprilat.
Enoxacin
Naproxen may increase the neuroexcitatory activities of Enoxacin.
Enoxaparin
Naproxen may increase the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Naproxen may increase the anticoagulant activities of Enoxaparin.
Epirubicin
Naproxen may decrease the excretion rate of Epirubicin which could result in a higher serum level.
Eplerenone
Naproxen may decrease the antihypertensive activities of Eplerenone.
Epoprostenol
The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Naproxen.
Eprosartan
The risk or severity of adverse effects can be increased when Eprosartan is combined with Naproxen.
Esmolol
Naproxen may decrease the antihypertensive activities of Esmolol.
Estrone
The risk or severity of adverse effects can be increased when Naproxen is combined with Estrone.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Naproxen.
Ethacrynate
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Naproxen.
Ethacrynic Acid
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Naproxen.
Ethylenediaminetetraacetate
Naproxen may increase the anticoagulant activities of Edetic Acid.
Etidronate
The risk or severity of adverse effects can be increased when Naproxen is combined with Etidronic acid.
Etidronic Acid
The risk or severity of adverse effects can be increased when Naproxen is combined with Etidronic acid.
Etodolac
The risk or severity of adverse effects can be increased when Naproxen is combined with Etodolac.
Etofenamate
The risk or severity of adverse effects can be increased when Naproxen is combined with Etofenamate.
Etoricoxib
The risk or severity of adverse effects can be increased when Naproxen is combined with Etoricoxib.
Etravirine
The metabolism of Naproxen can be decreased when combined with Etravirine.
Evening primrose oil
The risk or severity of adverse effects can be increased when Naproxen is combined with Evening primrose oil.
Felbinac
The risk or severity of adverse effects can be increased when Naproxen is combined with Felbinac.
Felodipine
The metabolism of Naproxen can be decreased when combined with Felodipine.
Fenbufen
The risk or severity of adverse effects can be increased when Naproxen is combined with Fenbufen.
Fenoprofen
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Naproxen.
Ferulic Acid
Naproxen may increase the anticoagulant activities of Ferulic acid.
Fleroxacin
Naproxen may increase the neuroexcitatory activities of Fleroxacin.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Naproxen.
Floxuridine
The metabolism of Naproxen can be decreased when combined with Floxuridine.
Fluconazole
The metabolism of Naproxen can be decreased when combined with Fluconazole.
Fludrocortisone
The risk or severity of adverse effects can be increased when Naproxen is combined with Fludrocortisone.
Fluindione
Naproxen may increase the anticoagulant activities of Fluindione.
Flumequine
Naproxen may increase the neuroexcitatory activities of Flumequine.
Flumethasone
The risk or severity of adverse effects can be increased when Naproxen is combined with Flumethasone.
Flunisolide
The risk or severity of adverse effects can be increased when Naproxen is combined with Flunisolide.
Flunisolide Anhydrous (obsolete)
The risk or severity of adverse effects can be increased when Naproxen is combined with Flunisolide.
Fluocinolone Acetonide
The risk or severity of adverse effects can be increased when Naproxen is combined with Fluocinolone Acetonide.
Fluocinonide
The risk or severity of adverse effects can be increased when Naproxen is combined with Fluocinonide.
Fluocortolone
The risk or severity of adverse effects can be increased when Naproxen is combined with Fluocortolone.
Fluorometholone
The risk or severity of adverse effects can be increased when Naproxen is combined with Fluorometholone.
Fluorouracil
The metabolism of Naproxen can be decreased when combined with Fluorouracil.
FLUPREDNIDENE
The risk or severity of adverse effects can be increased when Naproxen is combined with Fluprednidene.
Fluprednisolone
The risk or severity of adverse effects can be increased when Naproxen is combined with Fluprednisolone.
Flurandrenolide
The risk or severity of adverse effects can be increased when Naproxen is combined with Flurandrenolide.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Naproxen.
Fluticasone Furoate
The risk or severity of adverse effects can be increased when Naproxen is combined with Fluticasone furoate.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Naproxen is combined with Fluticasone propionate.
Fluvastatin
The metabolism of Naproxen can be decreased when combined with Fluvastatin.
Fluvoxamine
The metabolism of Naproxen can be decreased when combined with Fluvoxamine.
Folate
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Naproxen.
Folic Acid
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Naproxen.
Fondaparinux
Naproxen may increase the anticoagulant activities of Fondaparinux.
Fondaparinux sodium
Naproxen may increase the anticoagulant activities of Fondaparinux sodium.
Formestane
The risk or severity of adverse effects can be increased when Naproxen is combined with Formestane.
Fosinopril
The risk or severity of adverse effects can be increased when Naproxen is combined with Fosinopril.
Fosphenytoin
The metabolism of Naproxen can be increased when combined with Fosphenytoin.
Framycetin
Naproxen may decrease the excretion rate of Framycetin which could result in a higher serum level.
Furosemide
The therapeutic efficacy of Furosemide can be decreased when used in combination with Naproxen.
Gatifloxacin
Naproxen may increase the neuroexcitatory activities of Gatifloxacin.
Gatifloxacin Anhydrous
Naproxen may increase the neuroexcitatory activities of Gatifloxacin.
Gemeprost
The therapeutic efficacy of Gemeprost can be decreased when used in combination with Naproxen.
Gemfibrozil
The metabolism of Naproxen can be decreased when combined with Gemfibrozil.
Gemifloxacin
Naproxen may increase the neuroexcitatory activities of Gemifloxacin.
Gemifloxacin Mesylate
Naproxen may increase the neuroexcitatory activities of Gemifloxacin.
Gentamicin
Naproxen may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Grepafloxacin
Naproxen may increase the neuroexcitatory activities of Grepafloxacin.
Halcinonide
The risk or severity of adverse effects can be increased when Naproxen is combined with Halcinonide.
Halobetasol
The risk or severity of adverse effects can be increased when Naproxen is combined with Ulobetasol.
Haloperidol
The risk or severity of adverse effects can be increased when Naproxen is combined with Haloperidol.
Heparin
Naproxen may increase the anticoagulant activities of Heparin.
Hydralazine
Naproxen may decrease the antihypertensive activities of Hydralazine.
Hydrochlorothiazide
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Naproxen.
Hydrocortisone
The risk or severity of adverse effects can be increased when Naproxen is combined with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Naproxen.
Ibandronate
The risk or severity of adverse effects can be increased when Naproxen is combined with Ibandronate.
Ibandronic Acid
The risk or severity of adverse effects can be increased when Naproxen is combined with Ibandronate.
Ibuprofen
The risk or severity of adverse effects can be increased when Naproxen is combined with Ibuprofen.
Icatibant
The risk or severity of adverse effects can be increased when Naproxen is combined with Icatibant.
Idarubicin
Naproxen may decrease the excretion rate of Idarubicin which could result in a higher serum level.
Iloprost
The therapeutic efficacy of Iloprost can be decreased when used in combination with Naproxen.
Imidapril
The risk or severity of adverse effects can be increased when Naproxen is combined with Imidapril.
Indapamide
The therapeutic efficacy of Indapamide can be decreased when used in combination with Naproxen.
Indinavir
The metabolism of Naproxen can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Naproxen can be decreased when combined with Indinavir.
Indobufen
The risk or severity of adverse effects can be increased when Naproxen is combined with Indobufen.
Indomethacin
The risk or severity of adverse effects can be increased when Indomethacin is combined with Naproxen.
Irbesartan
The metabolism of Naproxen can be decreased when combined with Irbesartan.
Kanamycin
Naproxen may decrease the excretion rate of Kanamycin which could result in a higher serum level.
kanamycin A
Naproxen may decrease the excretion rate of Kanamycin which could result in a higher serum level.
Kebuzone
The risk or severity of adverse effects can be increased when Naproxen is combined with Kebuzone.
Ketoconazole
The metabolism of Naproxen can be decreased when combined with Ketoconazole.
Ketoprofen
The risk or severity of adverse effects can be increased when Naproxen is combined with Ketoprofen.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Naproxen.
Labetalol
Naproxen may decrease the antihypertensive activities of Labetalol.
Lapatinib
The metabolism of Naproxen can be decreased when combined with Lapatinib.
Latanoprost
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Naproxen.
Latanoprostene Bunod
The therapeutic efficacy of Latanoprostene Bunod can be decreased when used in combination with Naproxen.
Leflunomide
The metabolism of Naproxen can be decreased when combined with Leflunomide.
Lepirudin
Naproxen may increase the anticoagulant activities of Lepirudin.
Levobunolol
Naproxen may decrease the antihypertensive activities of Levobunolol.
Levofloxacin
Naproxen may increase the neuroexcitatory activities of Levofloxacin.
Levofloxacin Anhydrous
Naproxen may increase the neuroexcitatory activities of Levofloxacin.
Lidocaine
The metabolism of Naproxen can be decreased when combined with Lidocaine.
Limonene, (+)-
The risk or severity of adverse effects can be increased when Naproxen is combined with (4R)-limonene.
Lisinopril
The risk or severity of adverse effects can be increased when Naproxen is combined with Lisinopril.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Naproxen is combined with Lisinopril.
Lithium
The serum concentration of Lithium can be increased when it is combined with Naproxen.
Lithium Cation
The serum concentration of Lithium can be increased when it is combined with Naproxen.
Lornoxicam
The risk or severity of adverse effects can be increased when Naproxen is combined with Lornoxicam.
Losartan
The metabolism of Naproxen can be decreased when combined with Losartan.
Loteprednol
The risk or severity of adverse effects can be increased when Naproxen is combined with Loteprednol.
Lovastatin
The metabolism of Naproxen can be decreased when combined with Lovastatin.
Loxoprofen
The risk or severity of adverse effects can be increased when Naproxen is combined with Loxoprofen.
Lubiprostone
The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Naproxen.
Lumacaftor
The serum concentration of Naproxen can be increased when it is combined with Lumacaftor.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Naproxen is combined with Magnesium salicylate.
Manidipine
The metabolism of Naproxen can be decreased when combined with Manidipine.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Naproxen.
Meclofenamate
The risk or severity of adverse effects can be increased when Naproxen is combined with Meclofenamic acid.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Naproxen is combined with Meclofenamic acid.
Medronate
The risk or severity of adverse effects can be increased when Naproxen is combined with Technetium Tc-99m medronate.
Medrysone
The risk or severity of adverse effects can be increased when Naproxen is combined with Medrysone.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Naproxen.
Meloxicam
The risk or severity of adverse effects can be increased when Naproxen is combined with Meloxicam.
Mesalamine
Naproxen may increase the nephrotoxic activities of Mesalazine.
Methotrexate
The serum concentration of Methotrexate can be increased when it is combined with Naproxen.
Methyclothiazide
The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Naproxen.
Methylprednisolone
The risk or severity of adverse effects can be increased when Naproxen is combined with Methylprednisolone.
Metipranolol
Naproxen may decrease the antihypertensive activities of Metipranolol.
Metolazone
The therapeutic efficacy of Metolazone can be decreased when used in combination with Naproxen.
Metoprolol
Naproxen may decrease the antihypertensive activities of Metoprolol.
Metrizamide
Naproxen may decrease the excretion rate of Metrizamide which could result in a higher serum level.
Mexiletine
The metabolism of Naproxen can be decreased when combined with Mexiletine.
Midostaurin
The metabolism of Naproxen can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Naproxen can be increased when it is combined with Mifepristone.
Misoprostol
The therapeutic efficacy of Misoprostol can be decreased when used in combination with Naproxen.
Moexipril
The risk or severity of adverse effects can be increased when Naproxen is combined with Moexipril.
Mometasone
The risk or severity of adverse effects can be increased when Naproxen is combined with Mometasone.
Morniflumate
The risk or severity of adverse effects can be increased when Morniflumate is combined with Naproxen.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Naproxen is combined with Mycophenolic acid.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Naproxen.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Naproxen is combined with Mycophenolic acid.
Nabumetone
The risk or severity of adverse effects can be increased when Naproxen is combined with Nabumetone.
Nadolol
Naproxen may decrease the antihypertensive activities of Nadolol.
Nadroparin
Naproxen may increase the anticoagulant activities of Nadroparin.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Naproxen.
Nalidixic Acid
Naproxen may increase the neuroexcitatory activities of Nalidixic Acid.
Nebivolol
Naproxen may decrease the antihypertensive activities of Nebivolol.
Neomycin
Naproxen may decrease the excretion rate of Neomycin which could result in a higher serum level.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Naproxen.
Netilmicin
Naproxen may decrease the excretion rate of Netilmicin which could result in a higher serum level.
Nevirapine
The metabolism of Naproxen can be decreased when combined with Nevirapine.
Nicardipine
The metabolism of Naproxen can be decreased when combined with Nicardipine.
Niflumic Acid
The risk or severity of adverse effects can be increased when Naproxen is combined with Niflumic Acid.
Nilotinib
The metabolism of Naproxen can be decreased when combined with Nilotinib.
Nimesulide
The risk or severity of adverse effects can be increased when Naproxen is combined with Nimesulide.
Norfloxacin
Naproxen may increase the neuroexcitatory activities of Norfloxacin.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Naproxen is combined with Evening primrose oil.
Olmesartan
The risk or severity of adverse effects can be increased when Olmesartan is combined with Naproxen.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Naproxen.
Olsalazine
Naproxen may increase the nephrotoxic activities of Olsalazine.
Omacetaxine Mepesuccinate
The risk or severity of bleeding can be increased when Naproxen is combined with Omacetaxine mepesuccinate.
Omeprazole
The metabolism of Naproxen can be decreased when combined with Omeprazole.
Osimertinib
The serum concentration of Naproxen can be decreased when it is combined with Osimertinib.
Oxaprozin
The risk or severity of adverse effects can be increased when Naproxen is combined with Oxaprozin.
Oxprenolol
Naproxen may decrease the antihypertensive activities of Oxprenolol.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Naproxen is combined with Oxyphenbutazone.
Pamidronate
The risk or severity of adverse effects can be increased when Naproxen is combined with Pamidronate.
Pamidronic Acid
The risk or severity of adverse effects can be increased when Naproxen is combined with Pamidronate.
Paramethasone
The risk or severity of adverse effects can be increased when Naproxen is combined with Paramethasone.
Parecoxib
The risk or severity of adverse effects can be increased when Naproxen is combined with Parecoxib.
Paromomycin
Naproxen may decrease the excretion rate of Paromomycin which could result in a higher serum level.
Parthenolide
The risk or severity of adverse effects can be increased when Naproxen is combined with Parthenolide.
Pefloxacin
Naproxen may increase the neuroexcitatory activities of Pefloxacin.
Peginterferon Alfa-2b
The serum concentration of Naproxen can be increased when it is combined with Peginterferon alfa-2b.
Penbutolol
Naproxen may decrease the antihypertensive activities of Penbutolol.
Pentaerythritol Tetranitrate
Naproxen may increase the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentosan Polysulfate
Naproxen may increase the anticoagulant activities of Pentosan Polysulfate.
Perindopril
The risk or severity of adverse effects can be increased when Naproxen is combined with Perindopril.
Phenindione
Naproxen may increase the anticoagulant activities of Phenindione.
Phenobarbital
The metabolism of Naproxen can be increased when combined with Phenobarbital.
Phenprocoumon
Naproxen may increase the anticoagulant activities of Phenprocoumon.
Phenylbutazone
The risk or severity of adverse effects can be increased when Naproxen is combined with Phenylbutazone.
Phenytoin
The metabolism of Naproxen can be increased when combined with Phenytoin.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Naproxen.
Pindolol
Naproxen may decrease the antihypertensive activities of Pindolol.
Pioglitazone
The metabolism of Naproxen can be decreased when combined with Pioglitazone.
Pirarubicin
Naproxen may decrease the excretion rate of Pirarubicin which could result in a higher serum level.
Piretanide
The therapeutic efficacy of Piretanide can be decreased when used in combination with Naproxen.
Pirfenidone
The risk or severity of adverse effects can be increased when Naproxen is combined with Pirfenidone.
Piroxicam
The risk or severity of adverse effects can be increased when Piroxicam is combined with Naproxen.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Piroxicam is combined with Naproxen.
Plicamycin
Naproxen may decrease the excretion rate of Plicamycin which could result in a higher serum level.
Polythiazide
The therapeutic efficacy of Polythiazide can be decreased when used in combination with Naproxen.
Practolol
Naproxen may decrease the antihypertensive activities of Practolol.
Pralatrexate
The serum concentration of Pralatrexate can be increased when it is combined with Naproxen.
Prasterone
The risk or severity of adverse effects can be increased when Naproxen is combined with Prasterone.
Prednicarbate
The risk or severity of adverse effects can be increased when Naproxen is combined with Prednicarbate.
Prednisolone
The risk or severity of adverse effects can be increased when Naproxen is combined with Prednisolone.
Prednisone
The risk or severity of adverse effects can be increased when Naproxen is combined with Prednisone.
Pregnenolone
The risk or severity of adverse effects can be increased when Naproxen is combined with Pregnenolone.
Primidone
The metabolism of Naproxen can be increased when combined with Primidone.
Probenecid
The serum concentration of Naproxen can be increased when it is combined with Probenecid.
Propranolol
Naproxen may decrease the antihypertensive activities of Propranolol.
protein C, human
Naproxen may increase the anticoagulant activities of Protein C.
protein S, human
Naproxen may increase the anticoagulant activities of Protein S human.
Protocatechualdehyde
Naproxen may increase the anticoagulant activities of Protocatechualdehyde.
Pyrimethamine
The metabolism of Naproxen can be decreased when combined with Pyrimethamine.
Quinapril
The risk or severity of adverse effects can be increased when Naproxen is combined with Quinapril.
Quinethazone
The therapeutic efficacy of Quinethazone can be decreased when used in combination with Naproxen.
Quinine
The metabolism of Naproxen can be decreased when combined with Quinine.
Rabeprazole
The metabolism of Naproxen can be decreased when combined with Rabeprazole.
Ramipril
The risk or severity of adverse effects can be increased when Naproxen is combined with Ramipril.
Rescinnamine
The risk or severity of adverse effects can be increased when Naproxen is combined with Rescinnamine.
Resveratrol
The risk or severity of adverse effects can be increased when Naproxen is combined with Resveratrol.
Reviparin
Naproxen may increase the anticoagulant activities of Reviparin.
Reviparin sodium
Naproxen may increase the anticoagulant activities of Reviparin.
Rifampin
The metabolism of Naproxen can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Naproxen can be increased when combined with Rifapentine.
Rimexolone
The risk or severity of adverse effects can be increased when Naproxen is combined with Rimexolone.
Risedronate
The risk or severity of adverse effects can be increased when Naproxen is combined with Risedronate.
Risedronic Acid
The risk or severity of adverse effects can be increased when Naproxen is combined with Risedronate.
Rivaroxaban
Naproxen may increase the anticoagulant activities of Rivaroxaban.
Rofecoxib
The risk or severity of adverse effects can be increased when Naproxen is combined with Rofecoxib.
Ropinirole
The metabolism of Naproxen can be decreased when combined with Ropinirole.
Rosiglitazone
The metabolism of Naproxen can be decreased when combined with Rosiglitazone.
Rosoxacin
Naproxen may increase the neuroexcitatory activities of Rosoxacin.
Rucaparib
The metabolism of Naproxen can be decreased when combined with Rucaparib.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Naproxen.
Salicylamide
The risk or severity of adverse effects can be increased when Naproxen is combined with Salicylamide.
Salicylic Acid
The risk or severity of adverse effects can be increased when Naproxen is combined with Salicylic acid.
Salsalate
The risk or severity of adverse effects can be increased when Naproxen is combined with Salsalate.
Saralasin
The risk or severity of adverse effects can be increased when Saralasin is combined with Naproxen.
Sarilumab
Sarilumab may increase the immunosuppressive activities of Naproxen.
Secobarbital
The metabolism of Naproxen can be increased when combined with Secobarbital.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Naproxen is combined with Serrapeptase.
Sildenafil
The metabolism of Naproxen can be decreased when combined with Sildenafil.
Simeprevir
The metabolism of Naproxen can be decreased when combined with Simeprevir.
Sisomicin
Naproxen may decrease the excretion rate of Sisomicin which could result in a higher serum level.
Sodium Phosphate
Sodium phosphate may increase the nephrotoxic activities of Naproxen.
Sodium Phosphate, Monobasic
Sodium phosphate may increase the nephrotoxic activities of Naproxen.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Sodium phosphate may increase the nephrotoxic activities of Naproxen.
Sorafenib
The metabolism of Naproxen can be decreased when combined with Sorafenib.
Sotalol
Naproxen may decrease the antihypertensive activities of Sotalol.
Sparfloxacin
Naproxen may increase the neuroexcitatory activities of Sparfloxacin.
Spectinomycin
Naproxen may decrease the excretion rate of Spectinomycin which could result in a higher serum level.
Spirapril
The risk or severity of adverse effects can be increased when Naproxen is combined with Spirapril.
Spironolactone
Naproxen may decrease the antihypertensive activities of Spironolactone.
Streptomycin
Naproxen may decrease the excretion rate of Streptomycin which could result in a higher serum level.
Streptozocin
Naproxen may decrease the excretion rate of Streptozocin which could result in a higher serum level.
Sulfadiazine
The metabolism of Naproxen can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Naproxen can be decreased when combined with Sulfamethoxazole.
Sulfasalazine
The risk or severity of adverse effects can be increased when Naproxen is combined with Sulfasalazine.
Sulfisoxazole
The metabolism of Naproxen can be decreased when combined with Sulfisoxazole.
Sulindac
The risk or severity of adverse effects can be increased when Sulindac is combined with Naproxen.
Suprofen
The risk or severity of adverse effects can be increased when Naproxen is combined with Suprofen.
Tacrolimus
Naproxen may increase the nephrotoxic activities of Tacrolimus.
Tafluprost
The therapeutic efficacy of Tafluprost can be decreased when used in combination with Naproxen.
Talinolol
Naproxen may decrease the antihypertensive activities of Talinolol.
Talniflumate
The risk or severity of adverse effects can be increased when Talniflumate is combined with Naproxen.
Tamoxifen
The metabolism of Naproxen can be decreased when combined with Tamoxifen.
Technetium Tc 99m Medronate
The risk or severity of adverse effects can be increased when Naproxen is combined with Technetium Tc-99m medronate.
Telmisartan
The risk or severity of adverse effects can be increased when Telmisartan is combined with Naproxen.
Temafloxacin
Naproxen may increase the neuroexcitatory activities of Temafloxacin.
Tenofovir Disoproxil
The risk or severity of adverse effects can be increased when Naproxen is combined with Tenofovir disoproxil.
Tenoxicam
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Naproxen.
Teriflunomide
The serum concentration of Naproxen can be decreased when it is combined with Teriflunomide.
Theophylline
The metabolism of Naproxen can be decreased when combined with Theophylline.
Theophylline anhydrous
The metabolism of Naproxen can be decreased when combined with Theophylline.
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Naproxen is combined with Tiaprofenic acid.
Ticagrelor
The metabolism of Naproxen can be decreased when combined with Ticagrelor.
Ticlopidine
The metabolism of Naproxen can be decreased when combined with Ticlopidine.
Tiludronate
The risk or severity of adverse effects can be increased when Naproxen is combined with Tiludronic acid.
Tiludronic Acid
The risk or severity of adverse effects can be increased when Naproxen is combined with Tiludronic acid.
Timolol
Naproxen may decrease the antihypertensive activities of Timolol.
Timolol Anhydrous
Naproxen may decrease the antihypertensive activities of Timolol.
Tixocortol
The risk or severity of adverse effects can be increased when Naproxen is combined with Tixocortol.
Tobramycin
Naproxen may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Tolbutamide
The metabolism of Naproxen can be decreased when combined with Tolbutamide.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Naproxen is combined with Tolfenamic Acid.
Tolmetin
The risk or severity of adverse effects can be increased when Tolmetin is combined with Naproxen.
Torsemide
The therapeutic efficacy of Torasemide can be decreased when used in combination with Naproxen.
Trandolapril
The risk or severity of adverse effects can be increased when Naproxen is combined with Trandolapril.
Tranilast
The risk or severity of adverse effects can be increased when Naproxen is combined with Tranilast.
Travoprost
The therapeutic efficacy of Travoprost can be decreased when used in combination with Naproxen.
Treprostinil
The risk or severity of adverse effects can be increased when Treprostinil is combined with Naproxen.
Triamcinolone
The risk or severity of adverse effects can be increased when Naproxen is combined with Triamcinolone.
Triamterene
Naproxen may decrease the antihypertensive activities of Triamterene.
Trichlormethiazide
The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Naproxen.
Trimethoprim
The metabolism of Naproxen can be decreased when combined with Trimethoprim.
Trovafloxacin
Naproxen may increase the neuroexcitatory activities of Trovafloxacin.
Troxerutin
Naproxen may increase the anticoagulant activities of Troxerutin.
UNOPROSTONE
The therapeutic efficacy of Unoprostone can be decreased when used in combination with Naproxen.
Valdecoxib
The risk or severity of adverse effects can be increased when Naproxen is combined with Valdecoxib.
Valproate
The metabolism of Naproxen can be decreased when combined with Valproic Acid.
Valproic Acid
The metabolism of Naproxen can be decreased when combined with Valproic Acid.
Valrubicin
Naproxen may decrease the excretion rate of Valrubicin which could result in a higher serum level.
Valsartan
The metabolism of Naproxen can be decreased when combined with Valsartan.
Vancomycin
The serum concentration of Vancomycin can be increased when it is combined with Naproxen.
Vemurafenib
The serum concentration of Naproxen can be increased when it is combined with Vemurafenib.
Voriconazole
The metabolism of Naproxen can be decreased when combined with Voriconazole.
Warfarin
Naproxen may increase the anticoagulant activities of Warfarin.
Zafirlukast
The metabolism of Naproxen can be decreased when combined with Zafirlukast.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Naproxen.
Zofenopril
The risk or severity of adverse effects can be increased when Naproxen is combined with Zofenopril.
Zoledronic Acid
The risk or severity of adverse effects can be increased when Naproxen is combined with Zoledronic acid.
Zoledronic Acid Anhydrous
The risk or severity of adverse effects can be increased when Naproxen is combined with Zoledronic acid.
Zomepirac
The risk or severity of adverse effects can be increased when Naproxen is combined with Zomepirac.
